Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | CDC25C | P30307 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24626620 | 0.91 | NQO1 (0.42) | NQO1CYP3A4NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL23056897 | 0.84 | TSHR (0.47) | NQO1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL18174884 | 0.84 | NPC1 (0.38) | NQO1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL18174890 | 0.81 | IGF1R (0.44) | NQO1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL1102418 | 0.77 | HPGD (0.43) | CYP1A2CYP3A4NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6685019 | 0.76 | TSHR (0.45) | CYP3A4SMN1; SMN2 | |
| SCHEMBL2125548 | 0.76 | ALDH1A1 (0.46) | CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9319212 | 0.75 | MAOA (0.42) | NQO1CYP3A4CYP2C9SMN1; SMN2MAOA | |
| SCHEMBL18174883 | 0.75 | GPR3 (0.37) | CYP1A2CYP3A4CYP2C9CYP2C19NPC1 | |
| SCHEMBL18174891 | 0.75 | NPC1 (0.42) | CYP1A2CYP3A4CYP2C9CYP2C19NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-9478758-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, SLC25A21, SLC25A11 | NQO1 30/4885CYP1A2 1310/4885CYP3A4 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.